home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

102 rows where has_known_aptamer = 1, surface_class = "A_surface" and tier = "Tier 1.5" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: pdb_count_total, aptamer_count_pubmed

in_cev_map 2

  • 0 62
  • 1 40

has_structure 2

  • 1 72
  • 0 30

has_cryoEM 2

  • 0 70
  • 1 32

has_activation_state_pdb_pair 2

  • 0 101
  • 1 1

tier 1

  • Tier 1.5 · 102 ✖

surface_class 1

  • A_surface · 102 ✖

has_known_aptamer 1

  • 1 · 102 ✖
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P21359 NF1 Neurofibromin Tier 1.5 0.965 1 A_surface 26 87.19 1 0     1 2 32980430, 22617876 1 neurofibromatosis type 1 0.8844735398780649
P00813 ADA Adenosine deaminase Tier 1.5 0.957 1 A_surface 2 96.56 0 0     1 72 42012076, 41877526, 41762796, 41635914, 40403280, 40189053, 39856849, 39847085, 36796307, 33998617, 32043202, 30876536, 30060448, 27589406, 26606306, 25597304, 25521724, 25360869, 24976151, 24893272, 24682016, 24035856, 23462984, 23202335, 23037591, 22944024, 22613226, 41910181, 41791686, 41267360, 39673485, 39396299, 38583236, 36855421, 34241023, 33147453, 32546280, 30926472, 26605646, 24624989, 23373863, 22543727, 20345118, 19381549, 19378312, 18293985, 17440909, 17000903, 16856187, 16619330 1 Severe combined immunodeficiency due to adenosine deaminase deficiency 0.8556816060494579
P36888 FLT3 Receptor-type tyrosine-protein kinase FLT3 Tier 1.5 0.949 1 A_surface 11 75.94 0 0     1 6 41733039, 34364920, 31434881, 30237882, 29299123, 22411871 1 acute myeloid leukemia 0.8313389209288576
P16234 PDGFRA Platelet-derived growth factor receptor alpha Tier 1.5 0.945 1 A_surface 14 72.69 1 0     1 4 33334063, 32127469, 28010895, 30594071 1 gastrointestinal stromal tumor 0.8167494524079806
P04626 ERBB2 Receptor tyrosine-protein kinase erbB-2 Tier 1.5 0.934 1 A_surface 63 74.0 0 0     1 119 41836728, 41744190, 41540559, 41494763, 41413339, 41321156, 41297941, 40851486, 40761795, 40494827, 40403699, 40382399, 40223744, 40220375, 40120226, 40080161, 40056884, 39873777, 39809083, 39756158, 39748051, 39643321, 39609809, 39539244, 39263860, 39233482, 39177424, 38901393, 38813974, 38789508, 38693181, 38679242, 38604040, 38409854, 38066021, 37729138, 37659641, 37591183, 37522239, 37392577, 37038354, 36272296, 36255496, 36001395, 35504229, 34952586, 34476602, 34236165, 33876310, 33627408 1 non-small cell lung carcinoma 0.7789523142843545
P15529 CD46 Membrane cofactor protein Tier 1.5 0.934 1 A_surface 7 82.12 1 0     1 9 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 1 atypical hemolytic-uremic syndrome with MCP/CD46 anomaly 0.7798469882597787
P24394 IL4R Interleukin-4 receptor subunit alpha Tier 1.5 0.923 1 A_surface 10 54.75 0 0     1 3 32751068, 27819142, 22282665 1 asthma 0.742115080702623
P25445 FAS Tumor necrosis factor receptor superfamily member 6 Tier 1.5 0.921 1 A_surface 7 77.88 1 0     1 17 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 1 autoimmune lymphoproliferative syndrome type 1 0.7377210386590284
P16671 CD36 Platelet glycoprotein 4 Tier 1.5 0.921 1 A_surface 1 93.94 0 0     1 6 41713143, 41140242, 39762152, 33596054, 33291667, 31904170 1 platelet-type bleeding disorder 10 0.7360571429413174
P09758 TACSTD2 Tumor-associated calcium signal transducer 2 Tier 1.5 0.919 1 A_surface 7 82.69 0 0     1 4 41384307, 41241473, 40050871, 39250993 1 gelatinous drop-like corneal dystrophy 0.7293087728162646
P08637 FCGR3A Low affinity immunoglobulin gamma Fc region receptor III-A Tier 1.5 0.912 1 A_surface 15 85.69 0 0     1 2 41249026, 21531729 1 autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0.7061437347032623
P02786 TFRC Transferrin receptor protein 1 Tier 1.5 0.887 1 A_surface 22 86.69 1 0     1 3 39831311, 29046922, 32527800 1 TFRC-related combined immunodeficiency 0.623449899069336
P15260 IFNGR1 Interferon gamma receptor 1 Tier 1.5 0.862 1 A_surface 5 66.0 0 0     1 2 33667716 1 disseminated atypical mycobacterial infection 0.5414012388034828
P21926 CD9 CD9 antigen Tier 1.5 0.858 1 A_surface 5 88.56 0 0     1 17 41999228, 41625383, 40618375, 39266887, 38866706, 38057814, 37585601, 37351166, 37019008, 36704890, 34647460, 34505435, 33304477, 32730952, 32207293, 28959386 1 diphtheria 0.5261379875719714
P13591 NCAM1 Neural cell adhesion molecule 1 Tier 1.5 0.852 1 A_surface 7 79.5 0 0     1 1 36649818 1 smoking initiation 0.5071020926446286
Q92633 LPAR1 Lysophosphatidic acid receptor 1 Tier 1.5 0.843 1 A_surface 16 83.62 1 0     1 1 32065590 1 Epiretinal membrane 0.4757255248053499
Q9P121 NTM Neurotrimin Tier 1.5 0.824 1 A_surface 2 82.38 0 0     1 2 35699468, 26194558 1 smoking initiation 0.41382172436739945
Q14242 SELPLG P-selectin glycoprotein ligand 1 Tier 1.5 0.82 1 A_surface 1 50.38 0 0     1 1 25979951 1 glaucoma 0.40058604767334977
P08571 CD14 Monocyte differentiation antigen CD14 Tier 1.5 0.818 1 A_surface 1 84.75 0 0     1 14 41636061, 41542672, 41140242, 38477735, 38280803, 37162508, 36716100, 36475636, 32589412, 32515246, 30900705, 30563044, 25483705, 12498773 1 dengue disease 0.39219972762611355
P31785 IL2RG Cytokine receptor common subunit gamma Tier 1.5 0.804 1 A_surface 14 75.5 1 0     1 2 30800133, 33869115 0 gamma chain deficiency 0.8469997000418428
Q5ZPR3 CD276 CD276 antigen Tier 1.5 0.804 1 A_surface 3 83.31 1 0     1 1 38866941 1 response to statin 0.3471917147958521
P08100 RHO Rhodopsin Tier 1.5 0.804 1 A_surface 4 88.75 1 0     1 45 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 0 retinitis pigmentosa 0.8481942240861982
O95342 ABCB11 Bile salt export pump Tier 1.5 0.801 1 A_surface 8 83.12 1 0     1 1 36313979 0 progressive familial intrahepatic cholestasis type 2 0.8372060401943777
P10912 GHR Growth hormone receptor Tier 1.5 0.799 1 A_surface 9 58.69 0 0     1 5 38811951, 38477735, 31603904 0 Laron syndrome 0.8304020079647765
Q13308 PTK7 Inactive tyrosine-protein kinase 7 Tier 1.5 0.796 1 A_surface 1 82.69 0 0     1 110 41949051, 41786503, 41782379, 41780252, 41473803, 41172349, 41097888, 41065179, 41047832, 40987771, 40652441, 40618375, 40556592, 40488675, 40479736, 40415219, 40388621, 40274545, 40033943, 39933564, 39583320, 39468753, 39405917, 39315658, 39226482, 39211579, 39161311, 39127174, 38985770, 38922365, 38889444, 38773263, 38708542, 38695582, 38642044, 38466380, 38359901, 38148412, 38064592, 37974961, 37480788, 37473438, 37458448, 37247456, 37105082, 37003060, 36765879, 36722904, 36722696, 36471380 1 neurodegenerative disease 0.3194172724024113
P16410 CTLA4 Cytotoxic T-lymphocyte protein 4 Tier 1.5 0.787 1 A_surface 22 80.12 0 0     1 26 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 0 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 0.7906408646569979
P08648 ITGA5 Integrin alpha-5 Tier 1.5 0.785 1 A_surface 14 85.25 1 0     1 2 32174798, 38258032 1 skin disease 0.28465651599598124
P32942 ICAM3 Intercellular adhesion molecule 3 Tier 1.5 0.785 1 A_surface 1 87.12 0 0     1 3 40650261, 34730968, 17660953 1 lymphatic system disease 0.28331776251399693
Q96MS0 ROBO3 Roundabout homolog 3 Tier 1.5 0.784 1 A_surface 3 63.69 0 0     1 2 32369590 0 horizontal gaze palsy with progressive scoliosis 0.7813306356858872
P51654 GPC3 Glypican-3 Tier 1.5 0.779 1 A_surface 4 75.06 1 0     1 65 42083729, 41790019, 41653459, 41045695, 40825648, 40722645, 39998646, 39874791, 39608318, 39427046, 38910291, 38787447, 38621313, 38368644, 37665421, 36903516, 36457288, 36317566, 36072763, 35788872, 35699181, 35477501, 35051745, 34974867, 34306031, 33254049, 33080969, 32356075, 30347351, 30122918, 29675356, 29605994, 29277631, 27601357, 28263753 0 Simpson-Golabi-Behmel syndrome type 1 0.762708583613362
P20023 CR2 Complement receptor type 2 Tier 1.5 0.776 1 A_surface 9 74.94 1 0     1 1 33235290 0 immunodeficiency, common variable, 7 0.7543125403898414
P40126 DCT L-dopachrome tautomerase Tier 1.5 0.774 1 A_surface 1 89.12 0 0     1 1 27245069 0 oculocutaneous albinism type 8 0.7468868816172217
P08887 IL6R Interleukin-6 receptor subunit alpha Tier 1.5 0.768 1 A_surface 10 77.88 1 0     1 18 40853309, 38152968, 37034659, 36579647, 35890412, 33590853, 33340765, 32515246, 29211023, 28929152, 26552813, 26383776, 24481022, 24440854, 23235494, 22503683, 22258147, 22094809 0 rheumatoid arthritis 0.7269057706798291
Q00975 CACNA1B Voltage-dependent N-type calcium channel subunit alpha-1B Tier 1.5 0.767 1 A_surface 7 59.91 1 0     1 2 31118475, 25782368 0 Seizure 0.7217241968702018
P01732 CD8A T-cell surface glycoprotein CD8 alpha chain Tier 1.5 0.761 1 A_surface 8 78.19 0 0     1 2 38487531, 36979667 1 progressive supranuclear palsy 0.2036023725502463
P48023 FASLG Tumor necrosis factor ligand superfamily member 6 Tier 1.5 0.76 1 A_surface 3 80.19 0 0     1 1 16581027 0 autoimmune lymphoproliferative syndrome type 1 0.6984292519156657
P15391 CD19 B-lymphocyte antigen CD19 Tier 1.5 0.755 1 A_surface 4 62.22 1 0     1 13 41079126, 40652441, 38661725, 38148412, 36095289, 35829681, 34680368, 34364920, 32401486, 31912987, 29928472, 21127492 0 immunodeficiency, common variable, 3 0.6821072538733047
P32970 CD70 CD70 antigen Tier 1.5 0.75 1 A_surface 1 83.19 0 0     1 1 30609550 0 severe combined immunodeficiency due to CD70 deficiency 0.6651491980619259
Q96RJ3 TNFRSF13C Tumor necrosis factor receptor superfamily member 13C Tier 1.5 0.748 1 A_surface 8 63.03 1 0     1 1 23470998 0 immunodeficiency, common variable, 4 0.660711678987284
Q9HCK4 ROBO2 Roundabout homolog 2 Tier 1.5 0.744 1 A_surface 6 67.38 0 0     1 2 40616090, 31640794 0 familial vesicoureteral reflux 0.6460375744556555
Q8NER1 TRPV1 Transient receptor potential cation channel subfamily V member 1 Tier 1.5 0.738 1 A_surface 8 71.94 1 0     1 2 40855286, 28604222 0 migraine disorder 0.6269329225883602
P42658 DPP6 A-type potassium channel modulatory protein DPP6 Tier 1.5 0.737 1 A_surface 8 86.69 1 0     1 1 41313574 0 Autosomal dominant microcephaly 0.6225938492787458
P01876 IGHA1 Immunoglobulin heavy constant alpha 1 Tier 1.5 0.736 1 A_surface 14 81.88 1 0     1 2 37325361 1 IGA glomerulonephritis 0.12053726815801102
Q8N126 CADM3 Cell adhesion molecule 3 Tier 1.5 0.735 1 A_surface 1 84.38 0 0     1 2 39263947 0 Charcot-Marie-Tooth disease, axonal, type 2FF 0.6157861516342734
P01877 IGHA2 Immunoglobulin heavy constant alpha 2 Tier 1.5 0.726 1 A_surface 4 83.0 1 0     1 2 37325361 1 Chronic mucocutaneous candidosis 0.08794784007807564
P21709 EPHA1 Ephrin type-A receptor 1 Tier 1.5 0.724 1 A_surface 4 80.38 0 0     1 4 35283197, 24629635, 41325160 0 Alzheimer disease 0.5784090512493305
P31358 CD52 CAMPATH-1 antigen Tier 1.5 0.723 1 A_surface 1 67.19 0 0     1 1 39865939 0 chronic lymphocytic leukemia 0.5770414699711784
P18627 LAG3 Lymphocyte activation gene 3 protein Tier 1.5 0.72 1 A_surface 6 78.38 1 0     1 6 40761795, 38158454, 36603108, 28934318 0 melanoma 0.5672649687930189
P55259 GP2 Pancreatic secretory granule membrane major glycoprotein GP2 Tier 1.5 0.707 1 A_surface 4 78.62 1 0     1 3 36902059, 25483705, 24334484 0 type 2 diabetes mellitus 0.5235291484788168
O43653 PSCA Prostate stem cell antigen Tier 1.5 0.706 1 A_surface 1 81.31 0 0     1 2 41911185 0 duodenal ulcer 0.5197329863180171

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 777.836ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target